Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91 publications
Preservation of Humoral Immunity and Response to Vaccination in Patients With IgAN Treated With Felzartamab.
Journal: Kidney international reports
Published: April 29, 2026
Prolonged CD38 targeting with felzartamab in antibody-mediated kidney transplant rejection: a biomarker-guided open-label phase 2 extension.
Journal: The Lancet regional health. Europe
Published: March 30, 2026
Adjudicating Heart Failure Events in Participants Receiving Hemodialysis: Findings from Evaluation of Cinacalcet Hydrochloride Therapy to Lower Cardiovascular Events (EVOLVE) Trial.
Journal: American journal of nephrology
Published: July 15, 2025
Prognostic stratification in a diabetic kidney disease trial using plasma concentrations of soluble tumor necrosis factor receptor 1.
Journal: Kidney research and clinical practice
Published: June 24, 2025
Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy.
Journal: Kidney international
Published: February 01, 2025
Estimating the efficacy of felzartamab to treat antibody-mediated rejection using the iBox prognostication system.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: October 07, 2024
Felzartamab in Antibody-Mediated Rejection. Reply.
Journal: The New England journal of medicine
Published: September 25, 2024
Clinical Outcomes Among High-Risk Primary Care Patients With Diabetic Kidney Disease: Methodological Challenges and Results From the STOP-DKD Study.
Journal: Medical care
Published: July 22, 2024
Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy.
Journal: Kidney international reports
Published: June 03, 2024
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection.
Journal: The New England journal of medicine
Published: May 28, 2024
Selonsertib in Patients with Diabetic Kidney Disease: A Phase 2b Randomized Active Run-In Clinical Trial.
Journal: Journal of the American Society of Nephrology : JASN
Published: February 15, 2024
Last Updated: 09/26/2026